Burma Ironwood
Xylia xylocarpa
Xylia xylocarpa, an evergreen tree native to tropical regions of Asia, particularly India and Sri Lanka, has not been extensively used in traditional medicine. Computational studies have suggested potential applications for its compounds; Senbusine A was identified as a possible GCase stabilizer with favorable binding interactions. Additionally, research indicated that the evergreen trees exhibited more conservative water use, reduced photosynthesis rates, and enhanced photoprotection mechanisms during dry seasons compared to deciduous trees. The complete chloroplast genome of Xylia xylocarpa has been sequenced, providing insights into its genetic structure and phylogenetic position. Compounds from this plant showed potential anti-cholinesterase activity and improved memory in scopolamine-induced memory deficit models. No major safety concerns or drug interactions have been recorded to date.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Computational analysis identified Senbusine A from Xylia xylocarpa as a potential GCase stabilizer with favorable binding interactions.
- Evergreen trees showed reduced photosynthesis and enhanced photoprotection during the dry season compared to drought-deciduous trees.
- The study determined the complete chloroplast genome of Xylia xylocarpa, revealing its structure and phylogenetic position.
- The study found that compounds from Xylia xylocarpa showed potential anti-cholinesterase activity and improved memory in scopolamine-induced memory deficit models.
- Xylia xylocarpa had high levels of total free phenolics and tannins, but bioactive compounds were reduced by certain processing methods.
Frequently asked questions
What is Burma Ironwood?
Burma Ironwood (Xylia xylocarpa) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Burma Ironwood?
5 sourced findings are recorded for Burma Ironwood; the strongest carries evidence grade D. For example: Computational analysis identified Senbusine A from Xylia xylocarpa as a potential GCase stabilizer with favorable binding interactions.
How strong is the evidence for Burma Ironwood?
The strongest finding for Burma Ironwood carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Burma Ironwood safe? What are the side effects?
No major safety issues are recorded for Burma Ironwood in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Burma Ironwood interact with medications?
No drug interactions are recorded for Burma Ironwood in our sources. This does not rule them out — check with a pharmacist.
Is Burma Ironwood a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Effect of certain indigenous processing methods on the bioactive compounds of ten different wild type legume grains. literature abstract metadata
- T2 Photoprotection of evergreen and drought-deciduous tree leaves to overcome the dry season in monsoonal tropical dry forests in Thailand. literature abstract metadata
- T2 Anti-cholinesterases and memory improving effects of Vietnamese Xylia xylocarpa. literature abstract metadata
- T2 The complete chloroplast genome sequence of Xylia xylocarpa. literature abstract metadata
- T2 Structure-Based Identification of Allosteric Glucocerebrosidase Stabilizers from Xylia xylocarpa (Roxb.) Taub. for Parkinson's Disease Using LC-MS Profiling and Computational Analysis. literature abstract metadata